Brand Name: Carnicor

Generic Name: L-carnitine

Indications: Chronic myocardia ischemia, cardiac failure, angina pectoris, arrhytmia,
acute myocardial ischemia.
Drug Classification: Cardiac Drugs
Mechanism of Action: Facilitates the transport of fatty acids into cellular mitochondria.
The fatty acids are then used to produce energy.
Dosage: Chronic myocardia ischemia, cardiac failure Tab 2-3 tab tid. Inj 1 g bid-tid IV
(slowly over 2-3 min) or IM. Angina pectoris, arrhytmia tab 2 tab tid. Inj 1 g bid
IV (slowly over 2-3 min) or IM, acute myocardial ischemia.2 g bid-tid IV
(slowly over 2-3 min) or IM. Soln 50-100mg/kg body wt.
Special Precaution:
Standard assays for mutagenicity indicate that L-carnitine is not mutagenic.
Reproductive studies have been performed in rats and rabbits at doses up to 3.8
times the human doses used for the treatment of primary and secondary L-
carnitine deficiency on the basis of surface area and have revealed no evidence
of impaired fertility or harm to the fetus due to L-carnitine. However, there are
no adequate and well-controlled studies in pregnant women. Because animal
 reproduction studies are not always predictive of human response, supplemental
L-carnitine should be used by pregnant women only if clearly indicated and
only under medical supervision. It is not known whether L-carnitine is excreted
in human milk. Supplemental L-carnitine is not advised for nursing mothers.
Pregnancy Risk: B
Adverse Reaction: Nausea, Vomiting, cramps, diarrhea, body odor.
Contraindications: None Known
Form: Tablet 330 mg
Nursing Responsibilities:
 Monitor patient’s tolerance during the 1st week of theraphy and after increasing
dosage.
 Caution patient not to share drug with others.
 May give enteral liquid alone or dissolved in drinks or liquid food.
 Do not refrigerate solution.